ArticleDer Nervenarzt2026
[Psychopharmacological treatment of mentally ill offenders : A sample survey of forensic psychiatric patients admitted to two forensic psychiatric facilities in Hesse].
Article in Der Nervenarzt, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMany studies on psychopharmacological treatments in general psychiatric care exist, but only few are addressing the psychopharmacological treatment of mentally ill offenders. STUDY
designA sample survey was conducted at the Vitos Forensic Psychiatric Hospitals Gießen and Haina. Demographic, forensic, and pharmacological data were collected (nondigital patient files). All current inpatients were included. The primary objective of the study was a description of the pharmacological care of forensic patients.
resultsData from 416 forensic psychiatric patients were analyzed. More than half of the patients (55.05%) obtained psychopharmacological polypharmacy (use of ≥ 2 psychotropic drugs), the majority of which resulted from antipsychotic polypharmacy (37.7%). The most commonly combined agents were two second generation antipsychotics. Among the antipsychotics, olanzapine was prescribed most frequently (17.8%) and used in most cases (19/34) at off-label dosages. Clozapine was combined most often (11.5%) with other psychotropic drugs.
conclusionThe therapeutic advantage of combinations of psychotropic drugs compared to monotherapy is not sufficiently supported by clinical evidence. The therapeutic advantage of combination therapies compared with monotherapy is not sufficiently established for psychopharmacotherapy in general, and for antipsychotic treatment in particular. However, the high prevalence of psychopharmacological polypharmacy in this study reflects routine clinical practice in forensic psychiatry. Further analyses are meaningful to evaluate specific substance combinations in terms of drug safety and off-label use.
Indexed as
Identifiers
42768101What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.